Cowpox taught the world how to defeat smallpox
Edward Jenner named vaccines for Variolae vaccinae—cowpox—in 1798. Vaccination later erased smallpox worldwide and squeezed polio, measles, and tetanus into far smaller ranges. WHO counts licensed shots against twenty-five preventable infections; measles vaccine alone is estimated to stop about a million deaths each year.
A vaccine is a biological preparation that builds active acquired immunity against a specific infection or malignancy. It usually carries something that looks like the pathogen—weakened or killed microbes, toxins, or surface proteins—so the immune system learns the threat, clears it, and remembers it for later encounters. Shots may be prophylactic, blocking future wild infection, or therapeutic, fighting disease already present, including some cancers. A few even grant sterilizing immunity that stops infection outright.
Inoculation against smallpox was recorded in sixteenth-century China, with hints in the tenth century; Lady Mary Wortley Montagu brought the folk practice from Turkey to Britain in 1721. Jenner developed the first true vaccine from cowpox; in 1881 Louis Pasteur urged extending the name to new protective inoculations. Vaccination remains the most effective way to prevent infectious disease and drove smallpox’s eradication. Herd immunity makes outbreaks harder when most people are immunized. Endemic polio is now limited to parts of Afghanistan, Nigeria, and Pakistan, though missed child coverage and disinformation have delayed eradication dates.
U.S. measles cases fell from 763,094 in 1958 (552 deaths) to fewer than 150 a year after vaccines arrived. Protection can still fail from poor attenuation, dosing, or host non-response in an estimated 2–10% of people. Adaptive immunity may take one to two weeks; older adults show immunosenescence and often need adjuvants. Live attenuated products (measles, mumps, rubella, yellow fever, BCG) tend to last longer but are riskier for immunocompromised hosts. Side effects are usually mild; severe ones are rare. Vaccines also cut antibiotic resistance by shrinking pneumococcal pneumonia that once selected for penicillin-resistant strains.
Source: Vaccine
